Key result
Addition of non-infectious poliomyelitis virus activated poliomyelitis virus from a neutral virus-antibody mixture in a type-specific manner, correlating with protection-inducing activity in mice.
The antigenic potency of non-infectious poliomyelitis virus can be determined in tissue culture by its ability to liberate active virus from a neutral virus-antibody mixture, correlating with in vivo protection in mice.
Answers are grounded in this paper and cite their sources.
May enable in vitro potency testing of poliovirus antigens; leaves open translation beyond mouse models.
The activation of poliomyelitis virus from a "neutral" virus-antibody mixture by the addition of non-infectious virus is described. The phenomenon was demonstrated in tissue cultures using both Petri dishes and roller tubes. The reaction was found to be type-specific and a relationship between antigen dilution and number of plaques counted was established. The relative potency of vaccine preparations determined in this system was found to be comparable to their relative potency in respect to protection-inducing activity in mice.
No takes yet. Share an insight, caveat, or question.
U. Krech (1955) studied Poliomyelitis. Non-infectious poliomyelitis virus was evaluated on Activation of poliomyelitis virus from a neutral virus-antibody mixture. Addition of non-infectious poliomyelitis virus activated poliomyelitis virus from a neutral virus-antibody mixture in a type-specific manner, correlating with protection-inducing activity in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: